Search Results - "Siegert, Elise"
-
1
The European Scleroderma Trials and Research group (EUSTAR) task force for the development of revised activity criteria for systemic sclerosis: derivation and validation of a preliminarily revised EUSTAR activity index
Published in Annals of the rheumatic diseases (01-01-2017)“…Validity of European Scleroderma Study Group (EScSG) activity indexes currently used to assess disease activity in systemic sclerosis (SSc) has been…”
Get more information
Journal Article -
2
Systemic sclerosis-associated myositis features minimal inflammation and characteristic capillary pathology
Published in Acta neuropathologica (01-06-2021)“…Systemic sclerosis represents a chronic connective tissue disease featuring fibrosis, vasculopathy and autoimmunity, affecting skin, multiple internal organs,…”
Get full text
Journal Article -
3
The effect of omega-3 fatty acids on central nervous system remyelination in fat-1 mice
Published in BMC neuroscience (24-01-2017)“…There is a large body of experimental evidence suggesting that omega-3 (n-3) polyunsaturated fatty acids (PUFAs) are capable of modulating immune function…”
Get full text
Journal Article -
4
Sirt1 contributes critically to the redox-dependent fate of neural progenitors
Published in Nature cell biology (01-04-2008)“…Repair processes that are activated in response to neuronal injury, be it inflammatory, ischaemic, metabolic, traumatic or other cause, are characterized by a…”
Get full text
Journal Article -
5
Selenium and Copper as Biomarkers for Pulmonary Arterial Hypertension in Systemic Sclerosis
Published in Nutrients (25-06-2020)“…Circulating selenoprotein P (SELENOP) constitutes an established biomarker of Se status. SELENOP concentrations are reduced in inflammation and severe disease…”
Get full text
Journal Article -
6
Systemic sclerosis associated interstitial lung disease - individualized immunosuppressive therapy and course of lung function: results of the EUSTAR group
Published in Arthritis research & therapy (30-01-2018)“…Interstitial lung disease in systemic sclerosis (SSc-ILD) is a major cause of SSc-related death. Imunosuppressive treatment (IS) is used in patients with SSc…”
Get full text
Journal Article -
7
Outcomes of limited cutaneous systemic sclerosis patients: Results on more than 12,000 patients from the EUSTAR database
Published in Autoimmunity reviews (01-02-2020)“…Limited cutaneous systemic sclerosis (LcSSc) is the most common subset of SSc but it has been overlooked in the past years. At a time at which clinical trials…”
Get full text
Journal Article -
8
Comprehensive autoantibody profiles in systemic sclerosis: Clinical cluster analysis
Published in Frontiers in immunology (04-01-2023)“…Systemic sclerosis (SSc) belongs to the group of connective tissue diseases and is associated with the occurrence of disease-specific autoantibodies. Although…”
Get full text
Journal Article -
9
SIGLEC-1 in Systemic Sclerosis: A Useful Biomarker for Differential Diagnosis
Published in Pharmaceuticals (Basel, Switzerland) (28-09-2022)“…Systemic Sclerosis (SSc) is a clinically heterogeneous disease that includes an upregulation of type I interferons (IFNs). The aim of this observational study…”
Get full text
Journal Article -
10
Scleroderma Renal Crisis: Risk Factors for an Increasingly Rare Organ Complication
Published in Journal of rheumatology (01-02-2020)“…Scleroderma renal crisis (SRC) is a severe life-threatening manifestation in patients with systemic sclerosis (SSc). However, the knowledge about risk factors…”
Get full text
Journal Article -
11
Antibodies against chemokine receptors CXCR3 and CXCR4 predict progressive deterioration of lung function in patients with systemic sclerosis
Published in Arthritis research & therapy (22-03-2018)“…The chemokine receptors CXCR3 and CXCR4 are involved in the pathogenesis of fibrosis, a key feature of systemic sclerosis (SSc). It is hypothesized that…”
Get full text
Journal Article -
12
Autoimmunity to Sphingosine-1-Phosphate-Receptors in Systemic Sclerosis and Pulmonary Arterial Hypertension
Published in Frontiers in immunology (04-07-2022)“…Context Pulmonary arterial hypertension (PAH) is a frequent extracutaneous manifestation of systemic sclerosis (SSc). PAH is characterized by increased…”
Get full text
Journal Article -
13
Autologous hematopoietic stem cell transplantation improves long-term survival-data from a national registry
Published in Arthritis research & therapy (22-11-2022)“…Current recommendations on the management of systemic sclerosis (SSc) suggest that autologous hematopoietic stem cell therapy (HSCT) can be a rescue therapy…”
Get full text
Journal Article -
14
Performance of ENMC and EULAR/ACR classification systems applied to a single tertiary center cohort of dermatomyositis patients
Published in Neurological research and practice (15-11-2021)“…Abstract Background There have been numerous classification systems to diagnose corresponding myositis subtypes and select appropriate therapeutic measures…”
Get full text
Journal Article -
15
Endothelin B Receptor Immunodynamics in Pulmonary Arterial Hypertension
Published in Frontiers in immunology (09-06-2022)“…Introduction Inflammation is a major pathological feature of pulmonary arterial hypertension (PAH), particularly in the context of inflammatory conditions such…”
Get full text
Journal Article -
16
Analysis of omega-3 and omega-6 fatty acid-derived lipid metabolite formation in human and mouse blood samples
Published in Prostaglandins & other lipid mediators (01-04-2011)“…▶ Low amounts of omega-3 and omega-6 fatty acid-derived lipid metabolites in native human plasma. ▶ Calcium ionophore A23187 activates lipid metabolite…”
Get full text
Journal Article -
17
The Performance of Pulmonary Function Tests in Predicting Systemic Sclerosis-Interstitial Lung Disease in the European Scleroderma Trial and Research Database
Published in Diagnostics (Basel) (01-01-2024)“…In SSc, ILD is a major cause of morbidity and mortality. We aimed to investigate the performance of DLCO (diffusing capacity of lung carbon monoxide) and FVC…”
Get full text
Journal Article -
18
Are we too lenient with immunosuppression in severe cases of Systemic Sclerosis?
Published in Rheumatology (Oxford, England) (01-10-2016)Get full text
Journal Article -
19
Prediction of progression of interstitial lung disease in patients with systemic sclerosis: the SPAR model
Published in Annals of the rheumatic diseases (01-09-2018)“…To identify the predictive clinical characteristics and establish a prediction model for the progression of mild interstitial lung disease (ILD) in patients…”
Get more information
Journal Article -
20
Low-dose interleukin-2 selectively corrects regulatory T cell defects in patients with systemic lupus erythematosus
Published in Annals of the rheumatic diseases (01-07-2016)“…Defects in regulatory T cell (Treg) biology have been associated with human systemic autoimmune diseases, such as systemic lupus erythematosus (SLE). However,…”
Get more information
Journal Article